Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Eshelman Fredric N
Relationship:   10% Owner
City:   Wilmington
State:   NC
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   8,151,654    

Indirect Shares

  3,933,809      
Direct Value   $95,684,563    

Indirect Value

  $13,709,856      
Total Shares   12,085,463      
Total Value   $109,394,419      


Bausch Health Companies Inc
 $237,448 G1 Therapeutics Inc
 $797,500 Eyenovia Inc
 $953,301 Liquidia Technologies Inc
 $93,696,314 Bausch Health Companies Inc
 $237,448 G1 Therapeutics Inc
 $797,500 Eyenovia Inc
 $953,301 Liquidia Technologies Inc
 $93,696,314
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    7   
    3    

     Stock price went up :

    0   
    0    
     Stock price went down :
    7   
    3    
   
     Gain/Loss Ratio :
   -7.0   
   -3.0   
     Percentage Gain/Loss :
   -45.7%
 -43.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmaceutical Product Developme... PPDI Executive Chairman, Di... 2011-12-05 0 2011-12-05 0    Premium*  
            Furiex Pharmaceuticals, Inc. FURX Director, 10% Owner 2014-07-02 0 2014-07-02 0    Premium*  
            Bausch Health Companies Inc BHC Director 2017-05-05 38,298 2016-03-11 0    Premium*  
            G1 Therapeutics Inc GTHX Director, 10% Owner 2017-11-13 250,000 2017-11-13 3,439,151    Premium*  
            Eyenovia Inc EYEN Director 2020-09-11 1,292,787 2020-09-11 319,085    Premium*  
            Liquidia Technologies Inc LQDA 10% Owner 2020-11-25 6,570,569 2020-11-25 175,573    Premium*  
* Premium Members only  

Records found :    148         Free Registration Required For Full Results.    Limit: 25

Download
  Page 4 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-05-14 4 S $33.79 $305,160 D/D (9,000) 8,683,960 0 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-03-05 4 B $20.55 $313,120 D/D 15,237 1,992,887 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-03-06 4 B $20.87 $317,996 D/D 15,237 2,008,124 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2011-12-14 4 B $16.70 $334,935 D/D 20,056 1,960,291 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-03-08 4 B $22.52 $335,863 D/D 14,914 2,023,038 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-03-09 4 B $22.59 $344,204 D/D 15,237 2,038,275 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-05-23 4 B $17.73 $354,600 D/D 20,000 2,270,435 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2011-11-18 4 B $15.87 $374,929 D/D 23,625 1,647,734 3.92 -
LQDA Liquidia Technologies Inc 10% Owner   –       –       •   2020-11-23 4 S $3.16 $421,347 D/D (133,346) 6,871,398 0 %
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2011-12-01 4 B $17.60 $440,458 D/D 25,026 1,707,308 3.92 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2006-05-16 4 S $36.69 $447,470 D/D (12,180) 9,430,526 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2011-12-02 4 B $17.50 $483,910 D/D 27,652 1,734,960 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-05-24 4 B $17.99 $485,730 D/D 27,000 2,297,435 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-03-12 4 B $22.69 $507,144 D/D 22,351 2,060,626 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-03-13 4 B $23.45 $529,829 D/D 22,594 2,158,220 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-03-14 4 B $23.75 $539,434 D/D 22,713 2,180,933 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-05-22 4 B $16.93 $592,550 D/D 35,000 2,250,435 3.92 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-06-21 4 OE $9.11 $600,121 I/I 65,875 132,689 0 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2011-12-20 4 OE $9.11 $600,130 I/I 65,876 66,814 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2008-05-21 4 S $43.53 $609,718 D/D (14,000) 8,004,626 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-07-16 4 S $37.99 $627,749 D/D (16,434) 8,417,526 0 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-06-14 4 B $19.04 $649,892 D/D 34,133 2,666,361 3.92 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-05-01 4 S $34.63 $663,142 D/D (19,000) 8,831,627 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2007-06-01 4 S $36.91 $789,374 D/D (21,341) 8,600,827 0 -
FURX Furiex Pharmaceuticals, I... Director   –       •       •   2012-06-13 4 B $18.33 $810,058 D/D 44,193 2,632,228 3.92 -

  148  Records found
  1   2   3   4  5   6      
  Page 4 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed